Back to products
Cancer Medicine in Bangladesh
- All products
- Hepatitis B Virus28 products
Bladder Cancer39 products
Breast Cancer38 products
- Colorectal Cancer28 products
Diabetic25 products
- Endometrial Cancer29 products
- Hepatitis C Virus21 products
- Leukaemia3 products
- ONCOLOGY PRODUCTS29 products
- Rectal Cancer16 products
- Solid Tumor6 products
- Taskin50 products
- Anti-Diabetic6 products
- BEST SELLER16 products
- Bladder Cancer19 products
- Breast Cancer19 products
- Colon & Rectal Cancer12 products
- Colorectal Cancer10 products
- Diabetic12 products
- Endometrial Cancer13 products
- Hepatitis B Virus7 products
- Hepatitis C Virus9 products
- Ibrutinib4 products
- Kidney Cancer22 products
- Leukaemia12 products
- Liver Cancer22 products
- Lung Cancer24 products
- Lymphoma13 products
- Mantle Cell Lymphoma11 products
- Melanoma12 products
- Non-Hodgkin7 products
- ONCOLOGY18 products
- ONCOLOGY PRODUCTS41 products
- Tumor2 products
ACLOPAIN 100 MG
Indications Aceclofenac is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, toothache, trauma and
ELOPAG 25 MG
Elopag Tablet Eltrombopag Olamine 25 mg Everest Pharmaceuticals Ltd. Indications Eltrombopag Olamine is indicated in Chronic Immune (Idiopathic) Thrombocytopenia, Chronic Hepatitis
IBRUNIB 140 MG
IBRUNIB Strength 140 mg Packing 1 X 30 Capsules (Plastic Container) Storage Store below 30°C. Keep capsules in the original
IBRUXEN 140 MG
Ibruxen Capsule Ibrutinib 140 mg Everest Pharmaceuticals Ltd. Indications Mantle Cell Lymphoma: Ibrutinib is indicated for the treatment of patients with
JUPARIB 150 MG
Juparib Tablet Olaparib 150 mg Julphar Bangladesh Ltd. Also available as: 100 mg Indications Breast Cancer: Olaparib is indicated as monotherapy
LAPANIX 250 MG
LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase
LENVANIX 10 MG
Lenvanix (lenvatinib) 10 Mg Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor
LENVANIX 4 MG
Lenvanix (lenvatinib) 4 Mg Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor
LEVAT 10 MG
Levat Capsule Lenvatinib Mesylate 10 mg Julphar Bangladesh Ltd. Indications Lenvatinib is a kinase inhibitor that is indicated: For the treatment
LUCIBRU 140 MG
LUCIBRU Ibrutinib capsules 140mg 120 capsules Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton’s
LUCISUN 50
Brand name: LUCISUN 50 Pack: Pack of 28 capsules Key ingredient: Sunitinib Description LUCISUN 50 provides targeted therapy against various cancers.
LYNIB 100 MG
Lynib medicine 100mg Olaparib treats Ovarian cancer Brand name: Lynib Active ingredient: Olparib Content: 100mg Form: Capsules Package: 1 box of
